Abstract
Safety and Efficacy of Blinatumomab in Combination with a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-Positive Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have